Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 9.99
1.73 %
$ 1.28 B
Market Cap
-16.11
P/E
NEO - COST OF REVENUE
Cost of Revenue NEO - NeoGenomics, Inc.
370 M
LAST VALUE
7.29%
2 YEAR CAGR
11.81%
5 YEAR CAGR
23.10%
10 YEAR CAGR